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Sudden deathAbstract Nasal ﬁbrosarcoma is an infrequent malignant neoplasm. It usually presents as other
sarcomas in this region, with nasal obstruction and epistaxis. The ﬁnal diagnosis is based on the
histopathology and immunohistochemistry. We report the case of a 37-year-old man with a
3-month history of recurrent epistaxis and nasal obstruction. Nasal endoscopy conﬁrmed a right
nasal neoplasia. Computed tomography and magnetic resonance image showed the tumor. TEP
scan showed no metastasis. Complete removal was achieved through a combined surgery, by
endoscopic endonasal approach and by incision in the right upper oral vestibule. Fibrosarcoma
was found on histopathologic and immunohistochemistric examinations. After 12 months, the
postoperative course was uneventful and follow-up information showed no recurrence of
metastasis. However, in the 13th month, the patient suddenly died at home. Autopsy found no
obvious cause for his death. To the best of our knowledge, no case of a ﬁbrosarcoma of the nasal
cavity with sudden death has been previously reported in the English-language.
ª 2014 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Nasal ﬁbrosarcoma is an infrequent malignant neoplasm.1
These tumors only account for 7–10% of all the sarcomas of
the head and neck region.2 Only a few scattered cases have
been published. The etiology of ﬁbrosarcoma remains obscure
although radiation exposure has been thought to be the most
important etiological factor, followed by trauma, and underly-
ing conditions of bone like Paget’s disease, ﬁbrous dysplasia,or chronic osteomyelitis. The diagnosis is based on histopa-
thology and immunohistochemistry.
The treatment of choice is radical surgery. Radiation ther-
apy and chemotherapy3 can be used in inoperable cases. Prog-
nosis of the tumor is dependent on histological grade, tumor
size and adequate surgical treatment with disease free mar-
gins.3 We report a patient with nasal ﬁbrosarcoma, which
was successfully managed by endoscopic endonasal and oral
surgery who faced an unexplained sudden death in the 13th
month after surgery.
2. Case report
A 37-year-old man patient was referred to our hospital with
3 months history of enlarging mass in the right nasal cavity,ed.
Figure 2 This is a low-grade sarcoma composed of spindle cells
with little pleomorphism but with hyperchromatic nuclei and
moderate mitotic activity, arranged in fascicles and bundles with
occasional ‘‘herringbone’’ pattern (hematoxylin and eosin
stain · 200). Immunohistochemically, the cells are only positive
for vimentin and CD99 (not shown).
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tory was peptic ulcer. Endoscopic examination revealed a hem-
orrhagic black mass completely ﬁlling the anterior part of the
right cavity extending outwards from the vestibule. No other
pathology was detected from the nasopharynx, oral cavity
and pharyngo-larynx. There were no palpable lymph nodes
in the neck. Routine hematological and biochemical tests were
normal. Computed tomography (CT) scans of the nose and
sinuses revealed an iso-dense mass ﬁlling the anterior part of
the nasal cavity without bony erosion. The paranasal sinuses,
orbita and cranial fossa were uninvolved. The mass exhibited
a low-intensity signal on a T1-weighted magnetic resonance
image (MRI) and a high-intensity signal on a gadolinium-
enhanced T1-weighted image and a T2-weighted image, mea-
suring 25 · 14 mm (Fig. 1). A biopsy was performed under
local anesthesia and the histopathologic examination reported
an unencapsulated spindle cell tumor with a herringbone pat-
tern without epithelial differentiation. The neoplastic cells were
homogeneous with little pleomorphism and little cytoplasm,
but containing hyperchromatic nuclei. Mitoses were seen at a
frequency of 7/10 high power ﬁelds. A variable amount of col-
lagen was observed (Fig. 2). Immunohistochemistry showed
the tumor to stain diffusely for CD99 and vimentin. Cytoker-
atins, EMA, actin, desmin, melanin A, S-100, CD33, CD34,
P63 and bcl.2 were negative. There was a moderate to focally
high Ki-67 staining of 50%. Abdominal and chest CT did not
show any evidence of metastases. PET scan showed an isolated
hypermetabolic localization (SUV= 33,84) in the ﬂoor of the
right nasal cavity without any secondary lesion (Fig. 3). Under
general anesthesia, the tumor was completely resected due to a
combined surgical approach, by nasal and by right upper oral
vestibule (Fig. 4).
The postoperative course of the patient was uneventful and
follow-up information showed no recurrence of metastasis after
12 months. However, in the 13th month, the patient suddenly
died at home. Autopsy found no obvious cause for his death.
3. Discussion
Fibrosarcomas are a malignant tumor of ﬁbroblasts. The
localization of the head and neck is uncommon. Approxi-Figure 1 Axial MR T2-weighted showing a well-deﬁned, high-
intensity tumor in the right nasal cavity.
Figure 3 PET scan showing an isolated hypermetabolic locali-
zation in the ﬂoor of the right nasal cavity.mately 19% of all soft-tissue sarcomas are ﬁbrosarcomas,
and only 16% of these occur in the head and neck.4 Only a
few cases have been published, but there are several compre-
hensive reviews on the histopathologic ﬁndings and treatment
results.
It usually presents in the third and fourth decades of life,
more commonly among males.2
The exact cause of ﬁbrosarcoma is not entirely understood.
However, studies have indicated that genetic alterations may
play a role. A chromosomal rearrangement has been found
in some ﬁbrosarcomas. Radiotherapy to the local site has been
proposed as a predisposing factor for increased risk of ﬁbro-
sarcoma. Disease processes like Paget’s disease and osteomy-
Figure 4 Tumor after resection.
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sarcomas developed in the bone.3
These neoplasms appear to originate in the periosteum
rather than in mucosal connective tissue.5 Fibrosarcomas are
usually unencapsulated, slowly growing spindle cell tumors.6
They may invade or atrophy adjacent bone by direct pressure.5
Nasal ﬁbrosarcoma demonstrates variable collagen produc-
tion, does not show differentiation in other types of tissue,
and can metastasize.1 These features allow establishment of a
differential diagnosis between inﬂammatory myoﬁbroblastic
tumor, ﬁbroma, desmoid ﬁbromatosis, and nasal ﬁbrosar-
coma. Other histological types have been described and can
lend confusion as synovial sarcoma and Ewing’s sarcoma. His-
tologically, nasal ﬁbrosarcomas are hypercellular lesions com-
posed of thin, elongated spindle cells arranged in long fascicles
and bundles intersecting at different angles (the herringbone
pattern) with a great degree of pleomorphism and nuclear aty-
pia and large number of mitoses, and may have areas of prom-
inent necrosis. Immunostaining for CD99 and vimentin is
positive. The tumor is negative for desmin, actin and S-100
protein.
Despite the paucity of cases of nasal ﬁbrosarcoma in the lit-
erature, the initial treatment of choice appears to be a wide
local excision. Endoscopic removal of nasal malignant tumors
has been thoroughly reported, with good oncologic results and
less morbidity than radical approaches.7
Radiotherapy has been used as an adjuvant treatment for
incomplete gross excision or positive microscopic margins.
The role of chemotherapy as a sole treatment for the head
and neck ﬁbrosarcoma warrants further study. Chemotherapy
has been employed as a neoadjuvant treatment in combinationwith radiotherapy as a palliative measure for patients with
unresectable tumors.2
Nasal ﬁbrosarcoma is usually associated with a high risk of
local recurrence, and low risk of distant metastases.3 Frequent
endoscopic and imaging controls are very useful to achieve
early detection of recurrences that can also be treated
endoscopically.8
Prognosis of the tumor is dependent on histological grade,
tumor size and adequate surgical treatment with disease free
margins. The 5-year survival rate for this disease is poor, rang-
ing from 20% to 35%.3
To the best of our knowledge, our patient represents the
ﬁrst case of nasal ﬁbrosarcoma who died of sudden death,
without metastasis, that has been reported in the English-lan-
guage literature. Sotolongo Vergo in Cuba report a case of
sudden death in a retroperitoneal ﬁbrosarcoma excised
4 month before and necropsy concluded to a right pulmonary
thromboembolism, abdominal ganglionar metastases and ret-
roperitoneal tumor extension.9 Until now, we have no explana-
tions for the death of our patient who have no medical history
particularly cardiac. We do not known how far we can relate
this death to his nasal ﬁbrosarcoma.
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